2VAG | Transferase | date | Aug 31, 2007 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex Novel Substituted Indole Inhibitor | ||||||||||||||
authors | A.C.W.Pike, A.N.Bullock, O.Fedorov, E.S.Pilka, E.Ugochukwu, F.Von A.Edwards, C.H.Arrowsmith, J.Weigelt, M.Sundstrom, K.Huber, F.Br S.Knapp | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Dual Specificity Protein Kinase Clk1 Chain: A Fragment: Kinase Domain, Residues 148-484 Synonym: Cdc-Like Kinase 1 Ec: 2.7.12.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Expression_system: Escherichia Coli Expression_system_taxid: 469008 Expression_system_strain: Bl21 (De3) Expression_system_variant: R3 Expression_system_plasmid: Plic-Sgc1 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.80 Å | ||||||||||||
ligand | SEP, TPO, V25 | enzyme | Transferase E.C.2.7.12.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing., Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, Szklarczyk D, Jensen LJ, Fabbro D, Trappe J, Rauch U, Bracher F, Knapp S, Chem Biol. 2011 Jan 28;18(1):67-76. PMID:21276940 |
Data retrieval |
View 2VAG in 3D |
Visual 3D analysis of 2VAG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2VAG |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |